PDF(Pubmed)
Abstract：
UNASSIGNED: Current treatment options for frozen shoulder are not established as the standard-of-care. The condition may resolve without intervention, but symptoms may persist despite treatment. Frozen shoulder is associated with inflammatory reactions that can reduce quality of life. Our aim was to determine whether triamcinolone acetonide, an immunosuppressive steroid, improved functional recovery when administered after arthroscopic capsular release (ACR) for frozen shoulder.
UNASSIGNED: We selected participants using inclusion and exclusion criteria designed to reduce the impact of potential confounding factors. Under general anesthesia, we performed ACR followed by manipulation to ensure adequate range of motion (ROM) and wound closure. In the steroid treatment group, we injected triamcinolone acetonide into the glenohumeral joint immediately prior to wound closure. The follow-up period was six months. To determine the efficacy of steroids in improving overall post procedure functional recovery we statistically analyzed data from various qualitative and quantitative variables.
UNASSIGNED: Our study consisted of 22 patients with frozen shoulder, 11 in each of the surgery-only and surgery with steroid injection groups. There were no significant differences between groups in the demographic data of the study participants. We observed significantly greater improvements in abduction ROM in the steroid treatment group than in the surgery-only group, at three and six months post treatment. Improvements in other movement parameters were similar in both groups. The steroid-treated group had a significantly higher numerical rating scale score for night pain at three months post treatment than the surgery-only group.
UNASSIGNED: Postoperative steroid treatment led to early recovery of the abduction ROM in patients with frozen shoulder. Hence, the current standard-of-care protocol for frozen shoulder and other similar conditions requiring surgical intervention should include this type of treatment. Therapeutic reduction in the inflammatory response following ACR can significantly improve prognosis and quality of life.
UNASSIGNED: We selected participants using inclusion and exclusion criteria designed to reduce the impact of potential confounding factors. Under general anesthesia, we performed ACR followed by manipulation to ensure adequate range of motion (ROM) and wound closure. In the steroid treatment group, we injected triamcinolone acetonide into the glenohumeral joint immediately prior to wound closure. The follow-up period was six months. To determine the efficacy of steroids in improving overall post procedure functional recovery we statistically analyzed data from various qualitative and quantitative variables.
UNASSIGNED: Our study consisted of 22 patients with frozen shoulder, 11 in each of the surgery-only and surgery with steroid injection groups. There were no significant differences between groups in the demographic data of the study participants. We observed significantly greater improvements in abduction ROM in the steroid treatment group than in the surgery-only group, at three and six months post treatment. Improvements in other movement parameters were similar in both groups. The steroid-treated group had a significantly higher numerical rating scale score for night pain at three months post treatment than the surgery-only group.
UNASSIGNED: Postoperative steroid treatment led to early recovery of the abduction ROM in patients with frozen shoulder. Hence, the current standard-of-care protocol for frozen shoulder and other similar conditions requiring surgical intervention should include this type of treatment. Therapeutic reduction in the inflammatory response following ACR can significantly improve prognosis and quality of life.
摘要：
■目前对冻结肩的治疗选择尚未确立为护理标准。这种情况可以在没有干预的情况下解决，但症状可能会持续，尽管治疗。冻结的肩膀与炎症反应有关，可以降低生活质量。我们的目的是确定曲安奈德，一种免疫抑制类固醇,关节镜下关节囊松解术（ACR）治疗冻结肩后，可改善功能恢复。
■我们使用旨在减少潜在混杂因素影响的纳入和排除标准来选择参与者。在全身麻醉下,我们进行了ACR,然后进行了操作,以确保足够的活动范围(ROM)和伤口闭合.在类固醇治疗组中，我们在伤口闭合前立即将曲安奈德注射到盂肱关节中。随访期为6个月。为了确定类固醇在改善术后整体功能恢复方面的功效，我们对各种定性和定量变量的数据进行了统计分析。
■我们的研究包括22例肩周炎患者，11在每个仅手术和类固醇注射手术组中。研究参与者的人口统计学数据在组间没有显着差异。我们观察到类固醇治疗组的外展ROM的改善明显大于单纯手术组。在治疗后三个月和六个月。两组其他运动参数的改善相似。在治疗后三个月，类固醇治疗组的夜间疼痛数字评分明显高于仅手术组。
■术后类固醇治疗导致冻结肩患者外展ROM的早期恢复。因此，目前对于冻结肩和其他需要手术干预的类似疾病的标准治疗方案应包括此类治疗.ACR后炎症反应的治疗性减少可以显着改善预后和生活质量。
■我们使用旨在减少潜在混杂因素影响的纳入和排除标准来选择参与者。在全身麻醉下,我们进行了ACR,然后进行了操作,以确保足够的活动范围(ROM)和伤口闭合.在类固醇治疗组中，我们在伤口闭合前立即将曲安奈德注射到盂肱关节中。随访期为6个月。为了确定类固醇在改善术后整体功能恢复方面的功效，我们对各种定性和定量变量的数据进行了统计分析。
■我们的研究包括22例肩周炎患者，11在每个仅手术和类固醇注射手术组中。研究参与者的人口统计学数据在组间没有显着差异。我们观察到类固醇治疗组的外展ROM的改善明显大于单纯手术组。在治疗后三个月和六个月。两组其他运动参数的改善相似。在治疗后三个月，类固醇治疗组的夜间疼痛数字评分明显高于仅手术组。
■术后类固醇治疗导致冻结肩患者外展ROM的早期恢复。因此，目前对于冻结肩和其他需要手术干预的类似疾病的标准治疗方案应包括此类治疗.ACR后炎症反应的治疗性减少可以显着改善预后和生活质量。
